NATALIE ELLISON: Open Payments
NPI 1881211043 · CLANTON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 17 payments from 11 companies in 2025. Trend: 2023 $465 · 2024 $539 · 2025 $351
Food & beverage: $351
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $79 |
| ABBVIE INC. | 2 | $47 |
| Abbott Laboratories | 2 | $47 |
| SHIELD THERAPEUTICS INC | 2 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| PFIZER INC. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
Products named: Ozempic, FREESTYLE LIBRE 3, ACCRUFER, QULIPTA, XIFAXAN, NURTEC ODT, JARDIANCE, FARXIGA.
Industry payments across AL — which companies pay providers there.
